• About us
  • Membership
  • Contact us
  • Tue April 14, 2026

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

Epidermolysis bullosa

Total:2

  • No lack of medical supplies for EB despite sanctions 2024-12-29 17:01

    No lack of medical supplies for EB despite sanctions

    TEHRAN –Despite sanctions, Iran’s Food and Drug Administration (IFDA) has managed to procure and store the essential medical supplies needed by Epidermolysis Bullosa (EB) patients, an official with IFDA has said.

  • Iran achieves technology to manufacture dressings for EB patients 2024-01-09 15:25

    Iran achieves technology to manufacture dressings for EB patients

    TEHRAN –An Iranian knowledge-based company has gained the technology for producing wound dressings for Epidermolysis Bullosa (EB) patients.

All Pages

Latest

  • Strait of Hormuz: U.S. Warships Retreat After Warning

  • IRGC's Warning: Enemies Beware of Our Fury

  • We stand firm in the battlefield and in the streets

  • Is Israel’s negotiation offer a trap for Lebanon?

  • US irrational demands bring Islamabad talks to inconclusive end

  • Luca Brasi sleeps with the fishes

  • 15299

  • Former UN expert says US responsible for failed Islamabad talks

  • Vance’s approval rating plunges to a historic low

  • Iran, Russia presidents discuss West Asia developments

  • Qalibaf: US failed to earn Iran’s trust in Islamabad talks; ‘diplomacy of power’ to continue

  • Lascaris: Trump’s Iran policy trapped by delusions and unilateralism

  • The heavy shadow of the Strait of Hormuz over global economic calculations

  • Iran medical body identifies over 3,750 victims of US–Israeli aggression 

  • Hegseth faces backlash for calling the Persian Gulf the ‘Arabian Gulf’

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio